Fascioloidiasis

Download PDF

Recent Publications on Fascioloidiasis:
Prognostic significance of microsatellite alterations at 1p36 in cholangiocarcinoma. AIM: To investigate loss of heterozygosity (LOH) and microsatellite...	6th September, 2006	Department of Clinical Chemistry, Center for Research and Development of	World J Gastroenterol. 2006 Jul 21;12(27):4377-82.
Natural infection of a horse with Fascioloides magna. A 25-year-old Quarterhorse mare was euthanized for a variety of medical...	5th May, 2006	Department of Veterinary Population Medicine, College of Veterinary	J Vet Diagn Invest. 2005 Jul;17(4):382-5.
[Fascioliasis case in the patient with hepatitis A] There is some portion of patients with clinically manifested acute viral...	28th October, 2005	Infection Diseases, AIDS and Clinical Immunology Research Center;	Georgian Med News. 2005 Mar;(120):51-5.

Fascioloidiasis Patents:
US Patent No.	Title
6573060	Methods and compositions for targeting DNA metabolic processes using aminoglycoside derivatives
6537791	Mammalian DNA-dependent ATPase a polypeptides and fusions thereof
6531306	Polynucleotides encoding mammalian DNA-dependent ATPase A polypeptides
6180612	Methods and compositions for targeting DNA metabolic processes using aminoglycoside derivatives

BioPortfolio Ltd. offers e-mail and postal lists for Fascioloidiasis scientists - we have details of around 7 individuals working on Fascioloidiasis .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.